Radioligand
Top View
- A PET Study with [11C]CIMBI-36 and D-Amphetamine Challenge
- Development of Novel Pet Radioligands for Visualizing Beta Cell Mass and Amyloid Plaques
- (5-HT1A) Receptor Antag
- 11C-Mcn5652 and 11C-DASB As Serotonin Transporter Radioligands Under Various Experimental Conditions
- 12 Pharmacological Prerequisites for PET Ligands and Practical Issues in Preclinical PET Research
- Technetium-99M Radiopharmaceuticals: Status and Trends
- Radiopharmacy: an Update
- Altanserin Binding: a Pilot PET Study in Humans
- Dr. Bertrand Tavitian Dr. Andreas Jacobs Dr. Gitte Moos Knudsen Dr
- [ C]-DASB Binding to the Human Serotonin Transporter
- Radiopharmaceutical Therapy in Cancer: Clinical Advances and Challenges
- Effects of Reduced Endogenous 5-HT on the in Vivo Binding of the Serotonin Transporter Radioligand 11C-DASB in Healthy Humans
- Synthesis, Characterization and Biological Studies of Technetium-99M and Rhenium-188 Peptides
- PSMA Theranostics: Current Landscape and Future Outlook
- Toward Noninvasive Quantification of Brain Radioligand Binding by Combining Electronic Health 1273
- Current Directions in Radiopharmaceutical Research
- 11C-NS14492 As a Novel PET Radioligand for Imaging Cerebral A7 Nicotinic Acetylcholine Receptors: in Vivo Evaluation and Drug Occupancy Measurements
- Neuroinflammation PET Imaging: Current Opinion and Future Directions